Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

• Nicholas J. Izzo,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Jinbin Xu,

  Affiliation Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Chenbo Zeng,

  Affiliation Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Molly J. Kirk,

  Affiliations Departments of Neurology and Neuroscience, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Neurology, Northeastern University, Boston, Massachusetts, United States of America

  ⨯
• Kelsie Mozzoni,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Colleen Silky,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Courtney Rehak,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Raymond Yurko,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Gary Look,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Gilbert Rishton,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Hank Safferstein,

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• Carlos Cruchaga,

  Affiliation Department of Psychiatry, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Alison Goate,

  Affiliation Department of Psychiatry, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Michael A. Cahill,

  Affiliation School of Biomedical Sciences, Charles Sturt University, Wagga Wagga New South Wales, Australia

  ⨯
• Ottavio Arancio,

  Affiliation Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York, New York, United States of America

  ⨯
• Robert H. Mach,

  Affiliation Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Rolf Craven,

  Affiliation Department of Molecular and Biological Pharmacology, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
• Elizabeth Head,

  Affiliation Department of Molecular and Biological Pharmacology, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
• Harry LeVine III,

  Affiliation Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
• Tara L. Spires-Jones,

  Affiliations Departments of Neurology and Neuroscience, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, The University of Edinburgh, Center for Cognitive and Neural Systems and Euan MacDonald Centre for Motorneurone Disease, Edinburgh, Scotland

  ⨯
•  [ ... ],
• Susan M. Catalano

  * E-mail: scatalano@cogrx.com

  Affiliation Cognition Therapeutics Inc., Pittsburgh, Pennsylvania, United States of America

  ⨯
• [ view all ]
• [ view less ]